Product Code: RP-ID-10013457 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Chemicals |
Report ID: 10013457
Market Overview:
Global Polymerase Chain Reaction Technologies Market Size Study, by Technology (Real-Time PCR, Traditional PCR, Digital PCR) by Product (Reagents & Consumers, Instrument, Software, Services) by application (Clinical, Researcher, Forensics) by End-Use (Diagnostics Centre & Hospital, Biotech & Pharma Companies, Academics & Research Institution) Regional Forecasts 2017-2025
Global Polymerase Chain Reaction Technologies Market valued approximately USD 7 million in 2016 is anticipated to grow with a healthy growth rate of more than 7% over the forecast period 2017-2025. It is a medical device which is used for genetic engineering, genetics and molecular biology research. Increasing geriatric population, growing diagnostic centers and hospitals, rising prevalence of infectious diseases, advance technologies and increasing awareness personalized medicine are the major factors which drives the market growth. Minimize various PCR processes makes this one less tedious and may open various opportunities for this market. Furthermore, rising in funding for Research & Development activities and presence of major market players in developing countries are expected to provide new opportunity for the market in near future.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
 Real-Time PCR
 Traditional PCR
 Digital PCR
By Product:
 Reagents & Consumers
 Instruments
 Software
 Services
By Application:
 Clinical
 Researcher
 Forensics
By End-Use:
 Diagnostics Centre & Hospital
 Biotech & Pharma Companies
 Academic & Research Institution
By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025
Some of the key manufacturers involved in the market Agilent Technologies, Inc.
Biomeriux S.A, Bio-Rad Laboratories, Inc., Hoffmann-La Roche AG(ROCHE), Fluidigm Corporation, LGC Limited, Qiagen N.V., Sygnis AG, Tarkara Bio Inc., Thermo Fisher Scientific Inc. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Global Polymerase Chain Reaction Technologies Market in Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Bio-Rad Laboratories, Inc.,
Hoffmann-La Roche AG(ROCHE)
Fluidigm Corporation
LGC Limited
Qiagen N.V.
Sygnis AG
Tarkara Bio Inc.
Thermo Fisher Scientific Inc.
Related Reports
Proof of Quality & Reliability
